Similar articles for PMID: 23397471

Year	Number of Results
1991	1
1995	4
1997	4
1998	4
1999	1
2000	5
2001	4
2002	6
2003	3
2004	4
2006	4
2007	5
2008	4
2009	4
2010	3
2011	3
2012	3
2013	8
2014	15
2015	3
2016	1
2017	4
2018	8
2019	3
2020	9
2021	9
2022	8
2024	0

1

Combined hepatocellular cholangiocarcinoma: a case report and review of literature.

Singh S, Chakraborty S, Bonthu N, Radio S, Hussain SM, Sasson A. Singh S, et al. Dig Dis Sci. 2013 Jul;58(7):2114-23. doi: 10.1007/s10620-013-2585-1. Epub 2013 Feb 9. Dig Dis Sci. 2013. PMID: 23397471 Review. No abstract available.

2

Debating the presentation, morphology, origin, and prognosis of a combined hepatocellular-cholangiocarcinoma.

Lorenzon L, Castaldo P, Bartolazzi A, Rossi Del Monte S, Camboni A, Pilozzi E, Salvi PF, Ziparo V. Lorenzon L, et al. Dig Dis Sci. 2013 Aug;58(8):2423-4. doi: 10.1007/s10620-013-2720-z. Epub 2013 May 22. Dig Dis Sci. 2013. PMID: 23695879 No abstract available.

3

[Combined hepatocellular-cholangiocarcinoma].

Jeen YM, Jin SY. Jeen YM, et al. Korean J Hepatol. 2007 Dec;13(4):571-5. doi: 10.3350/kjhep.2007.13.4.571. Korean J Hepatol. 2007. PMID: 18159156 Korean. No abstract available.

4

The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis.

Tang Y, Wang L, Teng F, Zhang T, Zhao Y, Chen Z. Tang Y, et al. Int J Med Sci. 2021 Jan 1;18(1):187-198. doi: 10.7150/ijms.50883. eCollection 2021. Int J Med Sci. 2021. PMID: 33390787 Free PMC article.

5

[The value of CA19-9 in diagnosing hepatocellular carcinoma and intrahepatic cholangiocarcinoma].

Chen Y, Wang ZM, Ren ZG, Le F, Zhang BH, Xia JL, Ye SL, Tang ZY. Chen Y, et al. Zhonghua Gan Zang Bing Za Zhi. 2006 Apr;14(4):299-300. Zhonghua Gan Zang Bing Za Zhi. 2006. PMID: 16635306 Chinese. No abstract available.

6

[A case of AFP-producing cholangiocarcinoma with difficulty in differential diagnosis from hepatocellular carcinoma].

Omori J, Niimi A, Furuichi Y, Takeuchi E, Ishikawa T, Yanagisawa A, Ogihara S, Tsuchiya M, Misaka R, Shigemoto M, Kurihara T, Maeda A, Yamashita K, Aratake T, Kameoka S, Nishikawa T. Omori J, et al. Nihon Shokakibyo Gakkai Zasshi. 2004 Oct;101(10):1106-11. Nihon Shokakibyo Gakkai Zasshi. 2004. PMID: 15529784 Japanese. No abstract available.

7

[Synchronous double primary hepatic cancer: hepatocellular carcinoma and intrahepatic cholangiocarcinoma].

Kim JO, Jun DW, Jang K. Kim JO, et al. Korean J Gastroenterol. 2013 Aug 25;62(2):135-9. doi: 10.4166/kjg.2013.62.2.135. Korean J Gastroenterol. 2013. PMID: 24133714 Free article. Korean. No abstract available.

8

[In vivo proton magnetic resonance spectroscopy of hepatocellular carcinoma and cholangiocarcinoma].

Dong AS, Tian JM, Lu JP, Zuo CJ, Wang L, Wang J. Dong AS, et al. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2009 Apr;31(2):151-4. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2009. PMID: 19507591 Chinese.

9

Clinicopathological, radiologic, and molecular study of 23 combined hepatocellular-cholangiocarcinomas with stem cell features, cholangiolocellular type.

Chen J, He J, Deng M, Wu HY, Shi J, Mao L, Sun Q, Tang M, Fan XS, Qiu YD, Huang Q. Chen J, et al. Hum Pathol. 2017 Jun;64:118-127. doi: 10.1016/j.humpath.2017.01.016. Epub 2017 Apr 18. Hum Pathol. 2017. PMID: 28431889

10

Synchronous occurrence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in both lobes of the liver.

Topaloğlu S, Sağlam K, Çalık A, Cobanoğlu Ü, Öztürk MH. Topaloğlu S, et al. Turk J Gastroenterol. 2014 Apr;25(2):209-11. doi: 10.5152/tjg.2014.6188. Turk J Gastroenterol. 2014. PMID: 25003684 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

119 results

Results by year